Login / Signup

ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB-IIC Patients After 3 Years.

Marc D S MoncrieffBeverly UnderwoodJennifer GariochMartin HeatonNakul PatelEsther BastiaannetJosette Hoekstra-WeebersHarald Hoekstra
Published in: Annals of surgical oncology (2020)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • cross sectional